Novel mixed ligand complexes of coumarilate/N,N0-diethylnicotinamide with some transition…
Acknowledgements This study was financially supported by Sinop
14. Creaven B, Devereux M, Georgieva I, Karcz D, McCann M,
¨
University in Turkey (Project No. SUB-1901.14-01). The authors
Trendafilova N, et al. Molecular structure and spectroscopic
studies on novel complexes of coumarin-3-carboxylic acid with
Ni(II), Co(II), Zn(II) and Mn(II) ions based on density functional
theory. Spectrochim Acta A Mol Biomol Spectrosc. 2011;84(1):
275–85.
acknowledge Scientific and Technological Research Application and
Research Centre, Sinop University, Turkey, for the use of the Bruker
D8 QUEST diffractometer. This research was supported by the Sci-
ence Research Department of Hitit University (Project No:
FEF19004.15.005).
15. Gudasi KB, Shenoy RV, Vadavi RS, Patil MS, Patil SA. Synthesis,
characterisation and biological evaluation of lanthanide(III) com-
plexes
with
3-acetylcoumarin-o-aminobenzoylhydrazone
(ACAB). Chem Pharm Bull. 2005;53(9):1077–82.
16. Kostova I, Momekov G, Zaharieva M, Karaivanova M. Cytotoxic
activity of new lanthanum(III) complexes of bis-coumarins. Eur J
Med Chem. 2005;40(6):542–51.
References
¨
17. Kostova I, Momekov G. New zirconium(IV) complexes of cou-
marins with cytotoxic activity. Eur J Med Chem. 2006;41(6):
717–26.
18. Kostova I, Kostova R, Momekov G, Trendafilova N, Karaivanova
M. Antineoplastic activity of new lanthanide (cerium, lanthanum
and neodymium) complex compounds. J Trace Elem Med Biol.
2005;18(3):219–26.
19. Maucher A, Kager M, Von Angerer E. Evaluation of the antitu-
mour activity of coumarin in prostate cancer models. J Cancer
Res Clin Oncol. 1993;119(3):150–4.
¨
¨
¨ ¨
¨
¨
1. Kose DA, Ozturk B, S¸ahin O, Buyukgungor O. Mixed ligand
complexes of coumarilic acid/nicotinamide with transition metal
complexes. J Therm Anal Calorim. 2014;115(2):1515–24.
2. Kleiner HE, Vulimiri SV, Miller L, Johnson WH, Whitman CP,
DiGiovanni J. Oral administration of naturally occurring cou-
marins leads to altered phase I and II enzyme activities and
reduced DNA adduct formation by polycyclic aromatic hydro-
carbons in various tissues of SENCAR mice. Carcinogenesis.
2001;22(1):73–82.
¨
3. Tanew A, Ortel B, Rappersberger K, Honigsmann H.
20. Creaven BS, Egan DA, Kavanagh K, McCann M, Noble A, Thati
B, et al. Synthesis, characterization and antimicrobial activity of a
series of substituted coumarin-3-carboxylatosilver (I) complexes.
Inorg Chim Acta. 2006;359(12):3976–84.
21. Georgieva I, Trendafilova N, Kiefer W, Rastogi V, Kostova I.
Vibrational and theoretical study of coumarin-3-carboxylic acid
binding mode in Ce(III) and Nd(III) complexes. Vib Spectrosc.
2007;44(1):78–88.
22. Karaliota A, Kretsi O, Tzougraki C. Synthesis and characteriza-
tion of a binuclear coumarin-3-carboxylate copper(II) complex.
J Inorg Biochem. 2001;84(1):33–7.
23. Castellani CB, Carugo O. Studies on fluorescent lanthanide
complexes. New complexes of lanthanides(III) with coumarinic-
3-carboxylic acid. Inorg Chim Acta. 1989;159(2):157–61.
24. Georgieva I, Trendafilova N, Aquino AJ, Lischka H. Theoretical
study of metal-ligand interaction in Sm(III), Eu(III), and Tb(III)
complexes of coumarin-3-carboxylic acid in the gas phase and
solution. Inorg Chem. 2007;46(25):10926–36.
25. Georgieva I, Trendafilova N, Creaven BS, Walsh M, Noble A,
McCann M. Is the CO frequency shift a reliable indicator of
coumarin binding to metal ions through the carbonyl oxygen?
Chem Phys. 2009;365(1):69–79.
26. Mihaylov T, Trendafilova N, Kostova I, Georgieva I, Bauer G.
DFT modeling and spectroscopic study of metal–ligand bonding
in La(III) complex of coumarin-3-carboxylic acid. Chem Phys.
2006;327(2):209–19.
27. Roh S-G, Baek NS, Hong K-S, Kim HK. Synthesis and photo-
physical properties of luminescent lanthanide complexes based
on coumarin-3-carboxylic acid for advanced photonic applica-
tions. Bull Korean Chem Soc. 2004;25(3):343–4.
28. Ng SW. Coordination complexes of triphenyltin coumarin-3-
carboxylate with O-donor ligands:(coumarin-3-carboxylato)
triphenyltin–L (L = ethanol, diphenylcyclopropenone and quino-
line N-oxide) and bis [(coumarin-3-carboxylato) triphenyltin]–
L (L = triphenylphosphine oxide and triphenylarsine oxide). Acta
Crystallogr C. 1999;55(4):523–31.
5-Methoxypsoralen (Bergapten) for photochemotherapy:
bioavailability, phototoxicity, and clinical efficacy in psoriasis of
a new drug preparation. J Am Acad Dermatol. 1988;18(2):333–8.
4. Gill J, Heel RC, Fitton A. Amiodarone. Drugs. 1992;43(1):
69–110.
5. Hattori M, Hada S, Watahiki A, Ihara H, Shu YZ, Kakiuchi N,
et al. Studies on dental caries prevention by traditional medicines.
X. Antibacterial action of phenolic components from mace
against Streptococcus mutans. Chem Pharm Bull. 1986;34(9):
3885–93.
6. Erber S, Ringshandl R, Von Angerer E. 2-Phenylbenzo [b] fu-
rans: relationship between structure, estrogen receptor affinity
and cytostatic activity against mammary tumor cells. Anticancer
Drug Des. 1991;6(5):417–26.
7. Cui B, Chai H, Santisuk T, Reutrakul V, Farnsworth NR, Cordell
GA, et al. Novel cytotoxic 1H-cyclopenta [b] benzofuran lignans
from Aglaia elliptica. Tetrahedron. 1997;53(52):17625–32.
8. Kodama I, Kamiya K, Toyama J. Amiodarone: ionic and cellular
mechanisms of action of the most promising class III agent. Am J
Cardiol. 1999;84(9):20–8.
9. Lee SK, Cui B, Mehta RR, Kinghorn AD, Pezzuto JM. Cytostatic
mechanism and antitumor potential of novel 1H-cyclopenta
[b] benzofuran lignans isolated from Aglaiaelliptica. Chem Biol
Interact. 1998;115(3):215–28.
10. Hwang BY, Su B-N, Chai H, Mi Q, Kardono LB, Afriastini JJ,
et al. Silvestrol and episilvestrol, potential anticancer rocaglate
derivatives from Aglaia silvestris. J Org Chem. 2004;69(10):
3350–8.
11. Hayakawa I, Shioya R, Agatsuma T, Furukawa H, Naruto S,
Sugano Y. 4-Hydroxy-3-methyl-6-phenylbenzofuran-2-car-
boxylic acid ethyl ester derivatives as potent anti-tumor agents.
Bioorg Med Chem Lett. 2004;14(2):455–8.
12. Creaven BS, Devereux M, Karcz D, Kellett A, McCann M, Noble
A, et al. Copper(II) complexes of coumarin-derived Schiff bases
and their anti-Candida activity. J Inorg Biochem. 2009;103(9):
1196–203.
29. Ng SW, Kumar DasV. Tetramethylammonium bis (coumarin-3-
carboxylato) triphenylstannate ethanol solvate. Acta Crystallogr
C. 1997;53(8):1034–6.
30. Mosa A, Emara AA, Yousef J, Saddiq A. Novel transition metal
complexes of 4-hydroxy-coumarin-3-thiocarbohydrazone: phar-
macodynamic of Co(III) on rats and antimicrobial activity.
Spectrochim Acta A Mol Biomol Spectrosc. 2011;81(1):35–43.
13. Creaven BS, Egan DA, Karcz D, Kavanagh K, McCann M, Mahon
M, et al. Synthesis, characterisation and antimicrobial activity of
copper(II) and manganese(II) complexes of coumarin-6,7-dioxy-
acetic acid (cdoaH2) and 4-methylcoumarin-6,7-dioxyacetic acid
(4-MecdoaH2): X-ray crystal structures of [Cu(cdoa)(phen)2]
8.8H2O and [Cu(4-Mecdoa)(phen)2] 13H2O (phen = 1,10-
phenanthroline). J Inorg Biochem. 2007;101(8):1108–19.
123